Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180-Reference-Cited by-同舟云学术

Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180

Published:2015-11-30 Issue:1 Volume:238 Page:120-133
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Engelholm Lars H¹,Melander Maria C¹,Hald Andreas¹,Persson Morten²,Madsen Daniel H³,Jürgensen Henrik J¹,Johansson Kristina¹,Nielsen Christoffer¹,Nørregaard Kirstine S¹,Ingvarsen Signe Z¹,Kjaer Andreas²,Trovik Clement S⁴,Laerum Ole D¹⁵,Bugge Thomas H³,Eide Johan⁶,Behrendt Niels¹

Affiliation:

1. Finsen Laboratory/Biotech Research and Innovation Centre (BRIC); Rigshospitalet and University of Copenhagen; Denmark

2. Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging; Rigshospitalet and University of Copenhagen; Denmark

3. Proteases and Tissue Remodelling Section; National Institute of Dental and Craniofacial Research, National Institutes of Health; Bethesda MD USA

4. Department of Oncology/Orthopaedics; Haukeland University Hospital; Bergen Norway

5. Department of Clinical Medicine, Gade Laboratory of Pathology; University of Bergen; Norway

6. Department of Pathology; Haukeland University Hospital; Bergen Norway

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference60 articles.

1. Metastasis to bone: causes, consequences and therapeutic opportunities;Mundy;Nat Rev Cancer,2002

2. Mechanisms of bone metastasis;Mundy;Cancer,1997

3. Imaging transforming growth factor-β signaling dynamics and therapeutic response in breast cancer bone metastasis;Korpal;Nat Med,2009

4. Bone metastasis in prostate cancer: emerging therapeutic strategies;Sturge;Nat Rev Clin Oncol,2011

5. Seed, soil and secreted hormones: potential interactions of breast cancer cells with their endocrine/ paracrine microenvironment and implications for treatment with bisphosphonates;Wilson;Cancer Treat Rev,2012

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transcriptome and proteome profiling of activated cardiac fibroblasts supports target prioritization in cardiac fibrosis;Frontiers in Cardiovascular Medicine;2022-12-01

2. Endo180 (MRC2) Antibody–Drug Conjugate for the Treatment of Sarcoma;Molecular Cancer Therapeutics;2022-11-18

3. The endocytic receptor uPARAP is a regulator of extracellular thrombospondin-1;Matrix Biology;2022-08

4. Synthesis and In Vivo Evaluation of a Site-specifically Labeled Radioimmunoconjugate for Dual-Modal (PET/NIRF) Imaging of MT1-MMP in Sarcomas;Bioconjugate Chemistry;2022-07-22

5. uPARAP/Endo180: a multifaceted protein of mesenchymal cells;Cellular and Molecular Life Sciences;2022-04-22